DeepMed Research

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Hypertension in Young Adults Trial

Phase 2

Active, not recruiting

Conditions: Hypertension

Interventions: Device: Home BP monitoring with cuffed device
Device: Home BP monitoring with cuffed device + BP watch
Device: Home BP monitoring with cuffed device + BP patch

First Posted Date: 2022-05-11

Last Posted Date: 2025-03-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 120

Registration Number: NCT05370599

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy

Not Applicable

Withdrawn

Conditions: Leukemia
Plasma Cell Dyscrasia
Lymphoma

Interventions: Other: Web Application

First Posted Date: 2022-05-05

Last Posted Date: 2023-02-09

Lead Sponsor: University of California, San Francisco

Registration Number: NCT05362331

TReating Incontinence for Underlying Mental and Physical Health

Phase 4

Recruiting

Conditions: Urinary Incontinence, Urge
Overactive Bladder
Urinary Incontinence
Incontinence, Urge
Incontinence, Urinary
Incontinence

Interventions: Drug: Tolterodine Tartrate ER
Drug: Placebo
Drug: Mirabegron

First Posted Date: 2022-05-05

Last Posted Date: 2024-12-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 270

Registration Number: NCT05362292

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
Stanford University, Palo Alto, California, United States

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Phase 1

Recruiting

Conditions: Multiple Sclerosis, Primary Progressive
Multiple Sclerosis Relapse
Multiple Sclerosis (MS)
Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis, Chronic Progressive
Multiple Sclerosis Benign
Multiple Sclerosis Brain Lesion

Interventions: Drug: Clemastine Fumarate
Drug: Placebo

First Posted Date: 2022-05-04

Last Posted Date: 2024-07-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 74

Registration Number: NCT05359653

Locations: 🇺🇸
Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco, California, United States

Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy

Recruiting

Conditions: Intracranial Hemorrhage
Epilepsy
Gene Abnormality
Hypoxic-Ischemic Encephalopathy
Stroke
Neonatal Seizure

First Posted Date: 2022-05-04

Last Posted Date: 2025-04-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 300

Registration Number: NCT05361070

Locations: 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States

and more 5 locations

Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers

Not Applicable

Withdrawn

Conditions: Gastrointestinal Cancers
Gastrointestinal Cancer Metastatic

Interventions: Other: Electronic Patient Reported Outcomes platform
Other: Health Related Quality of Life Surveys

First Posted Date: 2022-05-03

Last Posted Date: 2024-05-08

Lead Sponsor: University of California, San Francisco

Registration Number: NCT05359042

AmbassADDOrs for Health Study

Not Applicable

Recruiting

Conditions: HIV Infections

Interventions: Behavioral: Comparison drug shops
Behavioral: Loyalty card program at drug shops & supply of HIVST and SRH products

First Posted Date: 2022-05-02

Last Posted Date: 2025-02-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 140

Registration Number: NCT05357144

Locations: 🇹🇿
Mwanza Province, Mwanza, Tanzania
🇹🇿
Shinyanga Province, Shinyanga, Tanzania

PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men

Not Applicable

Active, not recruiting

Conditions: Risk Reduction

Interventions: Behavioral: Motivational Interviewing Counselling
Device: Point-of-care Urine Tenofovir Measurement

First Posted Date: 2022-04-29

Last Posted Date: 2025-05-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT05353283

Locations: 🇺🇸
University of California, San Francisco/San Francisco General Hospital, San Francisco, California, United States

Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya

Phase 4

Active, not recruiting

Conditions: Tobacco Use
Tobacco Use Cessation

Interventions: Behavioral: Tobacco Use Cessation Counselling Sessions
Drug: Bupropion
Drug: Nicotine patch
Drug: Nicotine lozenge

First Posted Date: 2022-04-28

Last Posted Date: 2025-05-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 580

Registration Number: NCT05351606

Locations: 🇰🇪
Kenya Medical Research Institute (KEMRI), Kisumu, Kenya

Dental Block for Pain Relief in ED Dental Pain Patients

Recruiting

Conditions: Dental Pain

First Posted Date: 2022-04-28

Last Posted Date: 2025-02-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 195

Registration Number: NCT05351099

Locations: 🇺🇸
Community Regional Trauma and Burn Center, Fresno, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy